{"company":{"id":3781721,"name":"Fundamental Pharma","domain":"fundamentalpharma.com","url":"https://alion.io/company/fundamentalpharma"},"section":"news","answer":"Fundamental Pharma: 17 headlines on record, 2 headlines in the last 90 days. Its story counts 2 milestones.","figures":[{"label":"Headlines","value":"17"},{"label":"In 90 days","value":"2"},{"label":"Milestones","value":"2"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":14},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":2}],"news":[{"date":"2026-11-03","kind":"Blog","title":"Optimum TV - Brighter days ahead - next-generation therapies for treatment-resistant depression","url":"https://fundamentalpharma.com/optimum-tv-brighter-days-ahead-next-generation-therapies-for-treatment-resistant-depression/"},{"date":"2026-10-16","kind":"Blog","title":"pharmaphorum - Removing barriers in treatment-resistant depression","url":"https://fundamentalpharma.com/pharmaphorum-removing-barriers-in-treatment-resistant-depression/"},{"date":"2026-08-06","kind":"Podcast","title":"BioSpace Denatured podcast - The next treatment-resistant depression paradigm","url":"https://fundamentalpharma.com/biospace-denatured-podcast-the-next-treatment-resistant-depression-paradigm/"},{"date":"2026-07-14","kind":"Blog","title":"Technology Networks - Investigational Drug Could Provide At-Home Treatment-Resistant Depression Care","url":"https://fundamentalpharma.com/technology-networks-investigational-drug-could-provide-at-home-treatment-resistant-depression-care/"},{"date":"2026-06-02","kind":"Blog","title":"FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression candidate","url":"https://fundamentalpharma.com/fundamental-pharma-appoints-depression-drug-developer-dr-hans-eriksson-as-chief-medical-officer-to-advance-its-lead-treatment-resistant-depression-candidate/"},{"date":"2026-05-06","kind":"Blog","title":"pharmaphorum - Anglonordic Life Science 2026: A Focus On Execution","url":"https://fundamentalpharma.com/pharmaphorum-anglonordic-life-science-2026-a-focus-on-execution/"},{"date":"2026-05-01","kind":"Podcast","title":"Base to Base Biotech Podcast - 57: Keeping drugs cool, and treatment-resistant depression","url":"https://fundamentalpharma.com/base-to-base-biotech-podcast-57-keeping-drugs-cool-and-treatment-resistant-depression/"},{"date":"2026-04-30","kind":"Blog","title":"BiotechTV - From Germany: FundaMental Pharma aims to develop a dual-acting NMDA receptor modulator for treatment-resistant depression to improve on the risk profile seen today with esketamine","url":"https://fundamentalpharma.com/biotechtv-from-germany-fundamental-pharma-aims-to-develop-a-dual-acting-nmda-receptor-modulator-for-treatment-resistant-depression-to-improve-on-the-risk-profile-seen-today-with-esketamine/"},{"date":"2026-03-24","kind":"Blog","title":"BioWorld - With improved technologies, biomarkers, failed drugs may come into their own","url":"https://fundamentalpharma.com/bioworld-with-improved-technologies-biomarkers-failed-drugs-may-come-into-their-own/"},{"date":"2026-03-18","kind":"Blog","title":"Labiotech - Brain Awareness Week: could ongoing R&D spur neuroscience breakthroughs?","url":"https://fundamentalpharma.com/labiotech-brain-awareness-week-could-ongoing-rd-spur-neuroscience-breakthroughs/"},{"date":"2026-02-17","kind":"Press release","title":"FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference","source":"The Manila Times","url":"https://manilatimes.net/2026/02/17/tmt-newswire/globenewswire/fundamental-pharma-to-showcase-groundbreaking-approach-to-treatment-resistant-depression-at-bio-neuroscience-conference/2279215"},{"date":"2024-04-11","kind":"News","title":"FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer","source":"YahooFinance","url":"https://finance.yahoo.com/news/fundamental-pharma-appoints-dr-dirk-110000677.html"},{"date":"2024-03-19","kind":"News","title":"FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director","source":"markets.businessinsider.com","url":"https://markets.businessinsider.com/news/stocks/fundamental-pharma-appoints-industry-veteran-dr-lorenz-mayr-as-non-executive-director-1033178786"},{"date":"2024-02-07","kind":"News","title":"FundaMental Pharma GmbH announces publication of a groundbreaking Proof-of-Concept Study in Cell Reports Medicine using a TwinF Interface Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis","source":"YahooFinance","url":"https://uk.finance.yahoo.com/news/fundamental-pharma-gmbh-announces-publication-130000551.html"}],"story":[{"title":"New executive FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression c… · streetinsider.com","url":"https://streetinsider.com/Globe+Newswire/FundaMental+Pharma+appoints+depression+drug+developer+Dr.+Hans+Eriksson+as+Chief+Medical+Officer+to+advance+its+lead+treatment-resistant+depression+candidate/26586068.html"},{"title":"New executive FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer · YahooFinance","url":"https://finance.yahoo.com/news/fundamental-pharma-appoints-dr-dirk-110000677.html"}],"as_of":"2026-11-17","cite":"Fundamental Pharma, News. Alion, Nov 17, 2026. https://alion.io/company/fundamentalpharma/news","html_url":"https://alion.io/company/fundamentalpharma/news","json_url":"https://alion.io/company/fundamentalpharma/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T16:34:23Z"}}